Form 4: Stoke Therapeutics Former CFO Stephen Tulipano Reports Stock Option and Restricted Stock Unit Grants
SEC Filing
Former CFO of Stoke Therapeutics, Stephen J Tulipano, reports the acquisition of stock options and restricted stock units.
Summary
- Stephen J Tulipano, former CFO of Stoke Therapeutics, filed a Form 4 on June 7, 2024, reporting transactions related to the company's stock.
- On March 27, 2024, Tulipano acquired employee stock options for 60,000 shares with an exercise price of $14.17, vesting monthly starting April 15, 2024, and expiring on March 26, 2034.
- Additionally, Tulipano acquired 40,000 restricted stock units (RSUs) on March 27, 2024, vesting annually beginning March 15, 2025.
- Each RSU represents the right to receive one share of Stoke Therapeutics' common stock upon settlement.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.
Positives
- The grants of stock options and RSUs to a former executive could be seen as a way to maintain alignment of interests and incentivize continued positive contributions to the company's long-term success.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests.
Stakeholder Impact
- Shareholders can use this information to understand the compensation structure for former executives and their ongoing stake in the company.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of stock option and RSU acquisition |
| 04/15/2024 | First monthly vesting date for stock options |
| 03/15/2025 | First annual vesting date for RSUs |
| 03/26/2034 | Expiration date for stock options |
| 06/07/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.